#WORLDLUNGCANCERDAY2022 #WorldLungCancerDay 🫁 Dr Paola Perego and Dr Mattia Boeri discuss the usefulness of #liquidbiopsy🩸for the management of #lungcancer and the next frontiers of its clinical application👇 🔗podcasts.apple.com/us/podcast/tum… Istituto Tumori #biomarker #screening #lcsm

Great achievement - congratulations to our SAMO board member.

Excellent presentation of a contemporary trial of metronomic therapy for patients with advanced breast cancer #ESMO22

Please register for our „Highlights of the Year“ onsite session in Berne on November 24 chaired by Rolf Stahel and Solange Peters ! Link: samo-workshop.ch

The long-awaited initial results of the IBCSG 48-14/BIG 8-13 POSITIVE Trial will be presented at SABCS 2022 this Friday, Dec 9. Join online or in Hall 3 at 11:00am CT. @BIGagainstBC, Alliance for Clinical Trials in Oncology, SOLTI #cancerresearch, GEICAM - Cáncer de mama, SAKK, CancerTrialsIreland 🌈, ABCSG

Well deserved - congratulations Professor Viale

Stephanie Graff, MD, FACP, FASCO POLAR trial will probably answer the question: does 3yrs palbo+ET vs ET alone prolong iDFS in HR+/HER2- resected ILRR? ETOP IBCSG Partners Foundation @BIGagainstBC IEO

There’s a trial on #mondaymorning to answer the question raised by #SGBCC2023 panelists: ET+CDK4/6i vs ET for HR+HER2- #ILRR #POLAR trial ETOP IBCSG Partners Foundation @BIGagainstBC IEO Stefan Aebi

Just out in Annals of Oncology - Results of the IBCSG 24-02 / BIG 2-02 (SOFT) trial: "Genomic characterisation of hormone receptor-positive breast cancer arising in very young women". annalsofoncology.org/article/S0923-… @BIGagainstBC

Thanks Winette and EORTC for organizing a terrific workshop on pragmatic trials!

📢 Finally out #POSITIVE TRIAL ‼️wonderful news for #premenopausal #breastcancer patients who interrupt #EndocrineTherapy to Attempt #Pregnancy ETOP IBCSG Partners Foundation ⁦IEO⁩ ⁦NEJM⁩ nejm.org/doi/full/10.10…

Im Namen der Medizinischen Onkologie des Luzerner Kantonsspitals gehen unsere Glückwünsche zur verdienten Anerkennung an Prof. Ruedi Joss zentralplus.ch/gesellschaft/r…

#ESMOAcademy23: Gain expertise in methodology & interpretation of clinical trials, standard of care & future perspectives in main tumour types, pharmacokinetics & drug interactions at this comprehensive update on key topics in #medicaloncology. Register 👉ow.ly/Sq3750P0c1I

📢 Finally out ‼️Oral VEX (Vinorelbine, Cyclophosphamide, and Capecitabine) vs Paclitaxel for Metastatic ER+/ERBB2− Breast Cancer improves TTF & PFS jamanetwork.com/journals/jamao… ETOP IBCSG Partners Foundation IEO #metronomicVEX; #breastcancer #noalopecia #oralchemotherapy

Der Schweizerische Akkreditierungsrat hat dem Joint Medical Master die Akkreditierung ohne Auflagen erteilt. Das #Masterstudium in #Humanmedizin wird von der #UniLuzern in Zusammenarbeit mit der Universität Zürich angeboten. unilu.ch/news/akkrediti…

Ready for 2 days of exciting discussion ESMO - Eur. Oncology preceptorship on #breastcancer in Lugano Amazing faculty and super participants OncoAlert #OncoAlert #radonc #medonc #surgonc

Die Europäische Gesellschaft für medizinische Onkologie (ESMO) anerkennt das Tumorzentrum des LUKS als Zentrum mit integrierter Onkologie und Palliativbetreuung. Mehr Informationen finden Sie hier: luks.ch/newsroom/europ…

📣 Registration for #ESMOAcademy24 is now open. Get your update on the key topics in #medicaloncology. Register now: 👉 ow.ly/xq7V50QSkBN Raffaele Califano d.planchard Solange Peters Susana Banerjee Amanda Psyrri G Curigliano MD PhD Lizzy Smyth Teresa Macarulla

Heute ist #Weltkrebsforschungstag Die #Krebsforschung und die #Krebsliga Schweiz erhalten jährlich rund 200 Forschungsprojekte. Bei der Prüfung dieser Gesuche kommt der unabhängigen Wisschenschaftlichen Kommission eine zentrale Rolle zu.  ➡ issuu.com/krebsliga/docs… #WCRD

New publication: Genomic Characterization and Prognostic Significance of Human Epidermal Growth Factor Receptor 2–Low, Hormone Receptor–Positive, Early Breast Cancers From the BIG 1-98 and SOFT Clinical Trials ascopubs.org/doi/10.1200/PO…